Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1992Journal of Clinical Oncology

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.

View Full Paper
Ask AI
Bookmark
Share

Authors

DKDavid P. KelsenMemorial Sloan Kettering Cancer CenterOAOmar AtiqUniversity of North Carolina at Chapel Hill
Leonard B. Saltz
Leonard B. SaltzMemorial Sloan Kettering Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kelsen et al. (1992) studied this question.

synapsesocial.com/papers/6a7b294f2eb3c7e469f43fafhttps://doi.org/10.1200/jco.1992.10.4.541
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer.1986 · 114 citations
  2. 2Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.1991 · 393 citations
  3. 3Drug combinations in the treatment of gastric adenocarcinoma: a randomized Southwest Oncology Group study.1984 · 40 citations
  4. 4Rising incidence of adenocarcinoma of the esophagus and gastric cardia1991 · 2,382 citations
  5. 5The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer.1991 · 104 citations